'Standalone
net sales (including other operating income) of Bayer CropScience has declined
19.44% to Rs 791.50 crore. Operating
profit margin has declined from 20.95% to 12.20%, leading to 53.06% decline in
operating profit to Rs 96.60 crore. Raw
material cost as a % of total sales (net of stock adjustments) increased from
52.50% to 54.02%. Purchase of finished
goods cost fell from 7.03% to 3.20%.
Employee cost increased from 10.66% to 13.14%. Other expenses rose from 13.19% to
19.67%.
Other
income up 43% to Rs 29.6 crore.
PBIDT
fell 44.28% to Rs 126.2 crore. Provision
for interest fell 32.88% to Rs 4.9 crore.
Loan funds declined from Rs 73.50 crore as of 31 March 2023 to Rs 47.10
crore as of 31 March 2024. In...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|